Article
A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair
25 Oct 2019
Abstract excerpt
Despite the well-documented capacity of embryonic stem cells (ESCs) to differentiate into cardiomyocytes, transplantation of ESCs or ESC-derived cells is plagued by several formidable problems, including graft rejection, arrhythmias, and potential risk of teratomas. Life-long immunosuppression is a disease in itself. Transplantation of human ESC-derived cells in primates causes life-threatening arrhythmias, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
